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Ethical issues: invasive 
ventilation in amyotrophic 
lateral sclerosis
The fi rst man was a school headmaster. 
By his eye-gaze system he is able to order 
coins to enlarge his 10-year collection. His 
grandchildren extort presents from him in 
exchange for help. The second was a pre-
fect and even now insists that the fl owers 
in the garden represent the national fl ag. 
In spite of his gastrostomy, he still likes to 
sip his espresso from porcelain cups. The 
ventilation circuit 24/7 has not changed his 
custom to read the newspapers and listen 
to classical music in the living room. That 
girl is a young mum. She is fed by a tube, 
but she always makes her little child laugh 
with the dialectal phrases that she writes 
on the screen. The surgeon, every day in 
his electric wheelchair, reaches the creek 
to admire the sea. He stays in the sun as 
long as the ventilatory battery allows him 
to. The teacher, on the contrary, lives in 
a bed. Around her, her husband mumbles 
and grumbles about their terrible fortune 
and never smiles. Another was a shepherd, 
and he died because an electric blackout 
turned off the ventilator. The boy’s father, 
instead, is illiterate, but he is the best nurse 
you could possibly imagine.
Proposing tracheostomy to amyotrophic 
lateral sclerosis (ALS) patients is not an easy 
task. While you are choosing the fi rst words, 
all those different stories follow one another 
in your mind. As always, the phone is ring-
ing in the room and many people are waiting 
for you outside the door. It seems a common 
conversation between doctor and patient, to 
obtain the informed consent, but the point 
is what must be chosen: death or tracheo-
stomy? Years ago we had talked about the 
very modest benefi t from Riluzole on the 
progression of the disease. Many other 
drugs since then have been tried unsuccess-
fully, but unfortunately, at each new trial, 
the enthusiasm was soon substituted by 
disappointment. Visit after visit we observed 
the relentless advance of the disease that 
gradually stole all the forces and impaired 
speech, swallowing and respiratory func-
tions. Every time a new problem arose, he 
had asked us the same question: ‘what can 
we do?’, receiving, then incredulous, at the 
same vague answer. Neurodegenerative dis-
orders do not allow recovery. They deny 
the physician of the special privilege to treat 
a patient and give him a new lease of life. 
They disarm us. The last purpose of our 
job, then, is to relieve suffering and help to 
strengthen the patient’s resources to go on. 
Most of ALS patients do not have cognitive 
or behavioural changes, preserving irony, 
character, intelligence and an unaltered dig-
nity inside a body completely destroyed. 
They are ready to travel on a wheelchair, to 
eat by gastrostomy, to breathe with a mask 
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and to communicate by an eye-gaze system. 
It seems impossible, but the natural desire 
to live makes all these acrobatic solutions, 
and many more, acceptable. But despite all 
efforts, they will lose, and the natural course 
of the disease will end within 3–5 years, 
nearly invariably with severe respiratory 
failure. So here we are, in this room, at the 
fi nal crossroads. He can demand a peaceful 
death or choose to undergo tracheostomy, 
as the last card to play to live many more 
years. Both choices are irreversible, since in 
Italy it is illegal to stop the ventilation sup-
port, once started. Invasive ventilation in 
western countries is a procedure generally 
discouraged. The common opinion among 
physicians is that it prolongs the survival of 
the patients without slackening the disabil-
ity progression that inexorably proceeds to 
the locked-in state. This condition is con-
sidered incompatible with an acceptable 
quality of life. Paradoxically, the few stud-
ies that until now have assessed the quality 
of life of tracheostomised ALS patients have 
shown scores comparable with the general 
population.1 In fact, patients in the advanced 
stage of the disease suffer from respiratory 
symptoms and diffi culty in mucus manage-
ment, and often need to use a continuous 
ventilatory support by mask. From the per-
spective of the patient, therefore, to pass 
from this really uncomfortable condition to 
invasive ventilation by tracheostomy prob-
ably does not mean a worsening, especially 
if this change was previously considered 
and expected. It is common knowledge that 
tracheostomy ventilation provides a bet-
ter mucus management than non-invasive 
ventilation) and also relieves the respiratory 
symptoms. Is it then fair displaying all these 
concerns about the quality of life? However, 
the American Academy of Neurology and the 
EFNS (European Federation of Neurological 
Societies) guidelines,2 3 recommend inva-
sive ventilation to preserve quality of life 
of patients that want long-term ventilatory 
support. ‘What the patient wants’ is obvi-
ously declared as a fundamental principle 
on end-of-life issues and seems to explain 
the remarkable differences on the attitudes 
towards invasive ventilation between differ-
ent countries.4 In Japan, the highest rate of 
use of tracheostomy—positive pressure ven-
tilation in ALS (29%)5—is reported, while in 
the USA and North Europe only 2.1–5.4% 
of ALS patients receive this support in the 
terminal phase. This very meaningful differ-
ence expresses, in the common opinion, the 
distance between the western health system 
in which the patient’s will steers the medi-
cal decisions, and the opposite attitude to be 
guided by physicians, that is typical in the 
Japanese culture. Following this line of rea-
soning, invasive ventilation is so rarely used 
in western countries because almost all ALS 
patients in the terminal phase do not want 
to continue to live, and they freely decline to 
drag out their condition. Plenty of evidence 
6
is inconsistent with this hypothesis. The 
fi rst is that invasive ventilation by tracheo-
stomy requires enormous costs for ventila-
tion equipment and nursing care. In Japan, 
all these costs are fully covered by medical 
insurance. In North America, the health 
insurance hardly ever covers these costs, and 
in Europe, even when ventilatory support is 
provided (as is the case in Italy), the home 
nursing care weighs on the household bud-
get. So, is the patient really free to decide? 
A distinct problem is that the patient and his 
caregivers do not receive any social or psy-
chological support from the Health Systems. 
The human cost of such a devastating disease 
is incommensurable. By proposing tracheo-
stomy, what are we asking of the patient? 
If he can bear the costs of the treatment? If 
his wife, any son, any brother or a friend are 
ready to put all their energies into his care? 
In this anomalous consent request, ‘what the 
patient wants’ is just one of the reasons of 
the choice. Besides the individual troubles, 
the collective dynamics affect the patient’s 
decisions. Every word that the physician 
chooses to describe a procedure changes the 
idea that the patient forms about it and his 
agreement. It is natural that a doctor trusting 
to any operation will infuse the patient with 
faith, and vice versa. Unconsciously, physi-
cians every day run the risk to point out their 
intuitive or personal vision of the outcomes, 
overlooking the contrary published eviden-
ces. Equidistance is a very ambitious goal. 
The books written with eye-gaze system and 
the different personal stories of the patients 
prove that for some people also, a locked-in 
life is acceptable and even full of value. On 
the contrary, many other people think that 
a life without autonomy is not dignifi ed. 
Did we dedicate enough time to know the 
values of the patient before discussing with 
him about his end of life? Talking with our 
patient, we carry the burden of a multitude 
of concerns. Explaining the risks and benefi ts 
of the procedure seems to be like walking 
on burning coals, trying to pick out the most 
sublimating words. Meanwhile, the patient 
in front of us stares into space. Unbelievably 
quiet.
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